Investigation of Musculoskeletal System Disorders Seen in Automotive Industry Workers

July 19, 2024 updated by: Dr. Öğr. Üyesi Ömer Şevgin, Uskudar University
The aim of this study is to examine the musculoskeletal disorders seen in automotive industry workers.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

This study will be conducted as a face-to-face survey. Surveys will be created with Google Forms and will be filled out by the physiotherapist according to the participant's response.

Study Type

Observational

Enrollment (Estimated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Istanbul, Turkey
        • Recruiting
        • Uskudar University
        • Contact:
          • Ömer ŞEVGİN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

auto industry workers

Description

Inclusion Criteria:

  • Being between the ages of 25-60
  • Not having any psychological or neurological disorders
  • Being able to communicate in Turkish (written, verbal)
  • Being able to communicate cognitively adequately
  • Working full-time
  • Being employed in an automotive industry for at least 5 years

Exclusion Criteria:

  • Being under 18 or over 60
  • Working part-time
  • Being employed in the same business for less than 5 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work Productivity & Activity Impairment Questionnaire - General Health
Time Frame: 1 week
It is a tool developed to assess how health problems affect working life and daily activities in the general population. It measures the impact of health and symptom severity based on work productivity and leave time assessments and consists of 6 questions. These are; employment status, working hours, hours missed due to health problems, hours missed due to other reasons and the last two questions are the hours actually worked. It is scored from 0 to 10 points. The highest is 70, the lowest is 0. Higher scores indicate prolonged sick leave or impairment and reduced productivity.
1 week
Pittsburgh Sleep Quality Survey
Time Frame: 1 week
The scale includes a total of 24 questions. 19 of these questions are self-evaluation questions, and 5 of them are answered by the individual's spouse or a roommate. These 5 questions are used for clinical information only and are not included in the scoring. The scale questions that determine sleep quality include various factors related to sleep quality. These questions are to determine sleep duration, sleep latency, and the frequency and severity of specific sleep-related problems; 18 items were grouped as 7 component scores. The total score ranges from 0 to 21. A high total score indicates poor sleep quality. The scale does not indicate the presence of sleep disorders or the prevalence of sleep disorders. However, it is stated that a total score of 5 and above indicates poor sleep quality.
1 week
Disabilities of the Arm, Shoulder and Hand Questionnaire
Time Frame: 1 week
It was developed to evaluate functional status and symptoms by focusing on physical function in upper extremity injuries. According to the results of the survey; a result from 0-100 is obtained from each part; 0-no apology 100-maximum apology.
1 week
Rapid Upper Limb Assessment
Time Frame: 1 week
It is an ergonomics risk assessment method that quickly analyzes the employee's upper extremity from an ergonomic perspective. It evaluates upper extremity movements in 14 separate steps. 8 of these steps are scored for arm and hand position, and 6 for neck and trunk position, according to the table. The minimum Rapid Upper Limb Assessment Score = 1, and the maximum Rapid Upper Limb Assessment Score = 7. A high score means high risk.
1 week
Nordic Extended Musculoskeletal Questionnaire
Time Frame: 1 week
It is one of the questionnaires used to evaluate the severity and impact of musculoskeletal symptoms. In the survey, the frequency and severity of pain in the 'Neck, Shoulder, Upper Back, Elbow, Hand-wrist, Kala, Knee, Foot-ankle' areas of the body are evaluated in the last 12 months.It is a selection scale rather than a rating.
1 week
The McGill Pain Questionnaire
Time Frame: 1 week
McGill pain questionnaire-short form is used to evaluate patients' pain in terms of feeling and sensory. Pain level is defined with 15 words consisting of 11 sensory and 4 affective words. From these descriptive words, the patient should choose an answer that is compatible with him/her as "no (0)", "mild (1)", "moderate (2)", "severe (3)". In addition, the pain felt during the survey is measured with the Visual analog scale , and the total pain intensity of the pain is measured with a 6-point Likert scale. Pain is defined as "absent (0)" and "unbearable (5)" on the Likert scale. In total, pain scores between 0-45 (no pain=0, severe pain=45).
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Sude Asya ALŞAN, Uskudar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 19, 2024

Primary Completion (Estimated)

October 15, 2024

Study Completion (Estimated)

October 15, 2024

Study Registration Dates

First Submitted

June 26, 2024

First Submitted That Met QC Criteria

June 26, 2024

First Posted (Actual)

July 3, 2024

Study Record Updates

Last Update Posted (Actual)

July 22, 2024

Last Update Submitted That Met QC Criteria

July 19, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Uskudar13

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Work-related Illness

Clinical Trials on workers

Subscribe